Prevalence of chemosensitive disorders with Omicron infections and the possible impacts of vaccination
Errataetall: |
CommentOn: Int J Infect Dis. 2023 Mar;128:278-284. - PMID 36657518 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:129 |
---|---|
Enthalten in: |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 129(2023) vom: 01. Apr., Seite 205-206 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Vaira, Luigi Angelo [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anosmia |
---|
Anmerkungen: |
Date Completed 21.03.2023 Date Revised 03.07.2023 published: Print-Electronic CommentOn: Int J Infect Dis. 2023 Mar;128:278-284. - PMID 36657518 Citation Status MEDLINE |
---|
doi: |
10.1016/j.ijid.2023.02.007 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM353117285 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM353117285 | ||
003 | DE-627 | ||
005 | 20231226055256.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijid.2023.02.007 |2 doi | |
028 | 5 | 2 | |a pubmed24n1177.xml |
035 | |a (DE-627)NLM353117285 | ||
035 | |a (NLM)36805326 | ||
035 | |a (PII)S1201-9712(23)00054-1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Vaira, Luigi Angelo |e verfasserin |4 aut | |
245 | 1 | 0 | |a Prevalence of chemosensitive disorders with Omicron infections and the possible impacts of vaccination |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 21.03.2023 | ||
500 | |a Date Revised 03.07.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentOn: Int J Infect Dis. 2023 Mar;128:278-284. - PMID 36657518 | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 4 | |a Comment | |
650 | 4 | |a Anosmia | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Coronavirus | |
650 | 4 | |a Maxillofacial | |
650 | 4 | |a Olfactory dysfunction | |
650 | 4 | |a Olfactory function | |
650 | 4 | |a Otorhinolaryngology | |
650 | 4 | |a Rhinology | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a Smell | |
650 | 4 | |a Surgery | |
700 | 1 | |a De Riu, Giacomo |e verfasserin |4 aut | |
700 | 1 | |a Mayo-Yáñez, Miguel |e verfasserin |4 aut | |
700 | 1 | |a Gengler, Isabelle M |e verfasserin |4 aut | |
700 | 1 | |a Lechien, Jerome R |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases |d 1998 |g 129(2023) vom: 01. Apr., Seite 205-206 |w (DE-627)NLM094730857 |x 1878-3511 |7 nnns |
773 | 1 | 8 | |g volume:129 |g year:2023 |g day:01 |g month:04 |g pages:205-206 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijid.2023.02.007 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 129 |j 2023 |b 01 |c 04 |h 205-206 |